At a glance

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche's personalised healthcare strategy aims at providing medicines and diagnostics that enable tangible improvements in the health, quality of life and survival of patients. Founded in 1896, Roche has been making important contributions to global health for more than a century. Twenty-four medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and chemotherapy.

In 2014, the Roche Group employed 88,500 people worldwide, invested 8.9 billion Swiss francs in R&D and posted sales of 47.5 billion Swiss francs. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan.

For more information, please visit

Areas of activity in procurement

About 1.000 colleagues working in procurement ensure the global product and service availability, balancing costs, quality and sustainability. We have offices in over 45 countries and all continents. We leverage a supplier base of more than 70.000 partners.

Procurement is seen as a big contributor to the success of the company and involved in most business processes.

Facts and figures (2014)

Please visit
Purchasing volume: > 10 billion CHF
Procurement employees: 1000


If you are interested in procurement at Roche, please contact:

Stefan Kotthoff

Head of Global Procurement Roche Diagnostics